KNTE
Kinnate Biopharma Inc
Price:  
2.65 
USD
Volume:  
2,812,220.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KNTE WACC - Weighted Average Cost of Capital

The WACC of Kinnate Biopharma Inc (KNTE) is 9.4%.

The Cost of Equity of Kinnate Biopharma Inc (KNTE) is 15.00%.
The Cost of Debt of Kinnate Biopharma Inc (KNTE) is 5.00%.

Range Selected
Cost of equity 13.00% - 17.00% 15.00%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 8.4% - 10.3% 9.4%
WACC

KNTE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 2 2.17
Additional risk adjustments 0.0% 0.5%
Cost of equity 13.00% 17.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 8.4% 10.3%
Selected WACC 9.4%